FHB
PCRX icon

First Hawaiian Bank’s Pacira BioSciences PCRX Stock Holding History

First Hawaiian Bank’s Portfolio PCRX Stock Details PCRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-6,010
Closed -$203K – 862
2023
Q4 		$203K Sell
6,010
-1,090
-15% -$31.9K 0.01% 787
2023
Q3 		$218K Hold
7,100
– – 0.01% 771
2023
Q2 		$284K Hold
7,100
– – 0.01% 728
2023
Q1 		$290K Hold
7,100
– – 0.01% 729
2022
Q4 		$274K Sell
7,100
-601
-8% -$29.2K 0.01% 724
2022
Q3 		$410K Sell
7,701
-782
-9% -$43.5K 0.02% 578
2022
Q2 		$495K Buy
8,483
+8
+0.1% +$524 0.02% 549
2022
Q1 		$647K Sell
8,475
-1,966
-19% -$131K 0.02% 517
2021
Q4 		$628K Sell
10,441
-420
-4% -$23.2K 0.02% 543
2021
Q3 		$608K Hold
10,861
– – 0.02% 438
2021
Q2 		$659K Hold
10,861
– – 0.03% 410
2021
Q1 		$761K Buy
10,861
+185
+2% +$13.2K 0.03% 373
2020
Q4 		$639K Buy
10,676
+676
+7% +$39.6K 0.03% 393
2020
Q3 		$601K Buy
10,000
+880
+10% +$51.1K 0.03% 372
2020
Q2 		$479K Sell
9,120
-75
-0.8% -$3.13K 0.03% 435
2020
Q1 		$308K Buy
9,195
+75
+0.8% +$3.12K 0.02% 524
2019
Q4 		$413K Hold
9,120
– – 0.02% 552
2019
Q3 		$347K Sell
9,120
-175
-2% -$6.99K 0.02% 600
2019
Q2 		$404K Buy
+9,295
New +$395K 0.02% 530

Other funds holding PCRX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $7.3B AUM 41.96% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

First Hawaiian Bank's PCRX Position: Q1 2024 in Review

First Hawaiian Bank sold out of Pacira BioSciences (PCRX) in Q1 2024, closing a stake of 6,010 shares — an estimated $203K sold.

First Hawaiian Bank first reported a position in PCRX in Q2 2019 and held it in 19 quarters. The position peaked at $761K in Q1 2021. 270 funds tracked by Wall St. Rank hold PCRX as of Q1 2024.

  • First Hawaiian Bank reported no remaining Pacira BioSciences position as of Q1 2024 after selling out during the quarter.
  • First Hawaiian Bank sold 6,010 Pacira BioSciences shares in Q1 2024, an estimated $203K.
  • First Hawaiian Bank first reported a position in Pacira BioSciences in Q2 2019 and held it in 19 quarters.
  • First Hawaiian Bank's Pacira BioSciences position peaked at $761K in Q1 2021.
  • 270 funds tracked by Wall St. Rank held Pacira BioSciences as of Q1 2024.

Based on First Hawaiian Bank's 13F filing for Q1 2024, filed 5 Apr 2024.